Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results

Qi Tan, Alex L.K. Ng, George P.M. Cheng, Victor C.P. Woo, Pauline Cho

Research output: Journal article publicationJournal articleAcademic researchpeer-review

41 Citations (Scopus)


Purpose: The purpose of this study is to present the study design and one month’s preliminary results of a 2-year randomized trial, Combined Atropine with Orthokeratology (AOK), for myopia control study. Methods: Children aged 6 to <11 years and with 1.00–4.00 D myopia were randomly assigned to AOK group or ortho-k alone (OK) group. Subjects are required to attend routine ortho-k aftercare visits (first-overnight, 1 week, 2 weeks, 3 weeks, 1 month, and every 3 months after commencement of lens wear). Clinical outcomes, including lens performance, changes in refractive error, unaided vision, ocular adverse events, corneal staining, lens binding and centration, and axial length, are also assessed at 6-monthly data collection visit. Results: Data of 30 AOK and 34 OK subjects who had completed the 1-month visit were analyzed. No significant differences in baseline data were found between the two groups (P > 0.05). At the 1-month visit, first-fit success rate was 95%, with full myopia reduction. Mild corneal staining was observed in 23.3% and 30.9% and mild self-reported lens binding in 50% and 41% in AOK and OK groups, respectively, after 1-month lens wear. Mean (±standard deviation) change in axial length was significantly higher in AOK than OK subjects (AOK: −0.05 ± 0.05 mm; OK: −0.02 ± 0.03 mm) (P = 0.003). Conclusions: After 1 month of treatment, first-fit success rate of ortho-k lenses was high in both groups of subjects; addition of 0.01% atropine in AOK subjects did not affect the lens performance or clinical responses. These results provide the assurance that it is acceptable to continue this longitudinal study, as longer study duration, usually 2 years, is required to determine the effectiveness of treatment for myopia control.

Original languageEnglish
Pages (from-to)671-678
Number of pages8
JournalCurrent Eye Research
Issue number6
Early online date24 Jan 2019
Publication statusPublished - 3 Jun 2019


  • 0.01% atropine
  • combined therapy
  • Myopia control
  • orthokeratology

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Combined Atropine with Orthokeratology for Myopia Control: Study Design and Preliminary Results'. Together they form a unique fingerprint.

Cite this